SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-004094
Filing Date
2024-01-16
Accepted
2024-01-16 16:01:22
Documents
16
Period of Report
2024-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243329d1_8k.htm   iXBRL 8-K 41704
2 EXHIBIT 3.1 tm243329d1_ex3-1.htm EX-3.1 8690
3 EXHIBIT 10.1 tm243329d1_ex10-1.htm EX-10.1 40944
4 EXHIBIT 99.1 tm243329d1_ex99-1.htm EX-99.1 9413
8 GRAPHIC tm243329d1_ex99-1img001.jpg GRAPHIC 4613
  Complete submission text file 0001104659-24-004094.txt   306926

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20240110.xsd EX-101.SCH 3054
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20240110_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20240110_pre.xml EX-101.PRE 22385
10 EXTRACTED XBRL INSTANCE DOCUMENT tm243329d1_8k_htm.xml XML 3512
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 24535117
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)